Public company intelligence preview
WAYSTAR HOLDING CORP
122 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.
Snapshot
A narrow read on a much deeper workspace.
The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.
Insider compensation
Public aggregate: $13.7M average total compensation across covered insiders.
Governance movement
Public aggregate: 3 governance events in the last year.
Institutional ownership
Public aggregate: 300 holders from the latest quarter.
Restricted sales and governance
Public counts, not the investigation layer.
The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.
Market context
Basic quote context for the preview.
Company note
Context before the data.
Company Overview
Waystar Holding Corp. is a Healthcare sector company in the Health Information Services industry that provides cloud-based, AI-powered software for healthcare payment and revenue cycle management. Its platform supports the full payments lifecycle, including eligibility checks, prior authorization, claims submission, denial management, and patient payments, helping providers reduce billing errors and speed reimbursement. The business is highly diversified across more than 30,000 clients and over one million providers, with a recurring revenue model tied to subscriptions and transaction volumes. Waystar’s scale, deep EHR/PM integrations, and growing AI capabilities give it a strong position in a regulated, interoperability-dependent market.
Executive Compensation Practices
Executive compensation at Waystar is likely influenced by recurring revenue growth, net revenue retention, Adjusted EBITDA expansion, and cash flow generation, since those are central indicators of performance in a software and transaction-platform business. In 2025 and early 2026, the company showed strong revenue growth, margin expansion, and improved profitability, which can support incentive payouts tied to financial and operational milestones. Because Waystar is investing heavily in R&D, AI, and acquisitions like Iodine, compensation plans may also emphasize strategic execution, product integration, and client expansion rather than only short-term earnings. In the Healthcare and Health Information Services setting, equity-based compensation is typically important to retain technical and product talent, especially when stock-based compensation is meaningful and the business competes for engineering and AI expertise.
Insider Trading Considerations
Insider trading patterns at Waystar may be shaped by its recurring revenue profile, acquisition activity, and sensitivity to transaction volumes, which can create meaningful information asymmetry around quarterly results. Executives and directors may be especially cautious around periods when client expansion, large renewals, acquisition integration, or reimbursement-related trends are becoming visible but are not yet public. The company’s exposure to HIPAA, cybersecurity, and healthcare payment infrastructure risks also means insiders may have material nonpublic knowledge about operational disruptions or customer migrations, which can influence trading windows and blackout periods. For researchers and traders, watch insider activity around major events such as acquisition closings, earnings releases, financing changes, and any signs of client acceleration following competitor disruptions or industry cybersecurity incidents.
Unlock the full WAY insider intelligence workspace.
Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.